V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290005509 | 290004002 | null | null | null | null | 2017-08-04 | CHOP R | N | N | 290020131 | IRINOTECAN + MDG |
| 290005510 | 290004003 | 1.8 | 95.6 | Curative (C) | 2016-09-06 | 2016-09-18 | Capecitabine 35days + RT | null | N | 290020171 | CARBOPLATIN + PACLITAXEL |
| 290005511 | 290004003 | 1.65 | 37.8 | Palliative (P) | 2019-01-22 | 2019-01-25 | PEMBROLIZUMAB | 02 | N | 290020171 | CAPECITABINE + RT |
| 290005512 | 290004004 | 1.62 | null | Curative (C) | 2019-03-26 | 2019-04-15 | Fluorouracil 96hr infusion+R(4g/m2) | N | Y | 290020303 | CARBOPLATIN |
| 290005513 | 290004004 | 1.7 | 66.6 | Palliative (P) | 2018-05-11 | 2018-05-24 | CISPLATIN + FLUOROURACIL | N | N | 290020303 | NOT MATCHED |
| 290005514 | 290004004 | 1.66 | 57.3 | Adjuvant (A) | 2013-10-07 | 2013-10-17 | OCTREOTIDE | N | N | 290020303 | IPILIMUMAB + NIVOLUMAB |
| 290005515 | 290004004 | 1.68 | null | Curative (C) | 2013-03-24 | 2013-04-05 | Capecitabine | N | Y | 290020303 | CETUXIMAB |
| 290005516 | 290004004 | null | 56 | Palliative (P) | 2017-09-30 | 2017-10-27 | Doxorubicin 75mg/m2 | N | N | 290020303 | GEMCARBO |
| 290005517 | 290004005 | 1.75 | 60.3 | Neo-adjuvant (N) | 2017-11-24 | 2017-12-24 | Capecitabine | 02 | N | 290020465 | CAPECITABINE |
| 290005518 | 290004006 | 1.72 | 97.8 | Curative (C) | 2015-07-26 | 2015-07-26 | null | 2 | null | 290020477 | CISPLATIN + VINORELBINE |
| 290005519 | 290004007 | null | null | Palliative (P) | 2017-09-09 | 2017-09-11 | CHOP R - 21 days | N | N | 290020490 | LANREOTIDE |
| 290005520 | 290004008 | 1.6 | 67.3 | Palliative (P) | 2014-01-18 | 2014-01-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 290020508 | BENDAMUSTINE + RITUXIMAB |
| 290005521 | 290004009 | 0 | 0 | Palliative (P) | 2017-05-23 | 2017-10-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 290020543 | IPILIMUMAB + NIVOLUMAB |
| 290005522 | 290004009 | 1.75 | null | null | null | 2016-05-01 | Cisplatin +Fluorouracil (3 wk) | N | N | 290020543 | CISPLATIN + FLUOROURACIL |
| 290005523 | 290004009 | 1.75 | 97.8 | null | 2017-10-14 | 2017-11-08 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 290020543 | CISPLATIN + FLUOROURACIL |
| 290005524 | 290004009 | 1.6 | 67.8 | Curative (C) | 2015-01-30 | 2015-02-05 | Cetuximab 7 day (Cycle 1) | N | Y | 290020543 | CAPECITABINE + RT |
| 290005525 | 290004010 | 1.72 | 71.5 | Palliative (P) | 2017-02-01 | 2017-02-01 | Capecitabine 35days + RT | N | N | 290020639 | COMPARE TRIAL |
| 290005526 | 290004011 | null | 56 | Palliative (P) | 2017-10-19 | 2017-10-23 | CHOP R - 21 days | 2 | N | 290020654 | CISPLATIN + FLUOROURACIL |
| 290005527 | 290004011 | null | null | Curative (C) | 2016-03-29 | 2016-04-24 | CAP | N | N | 290020654 | BORTEZOMIB + THALIDOMIDE |
| 290005528 | 290004012 | 1.7 | 46 | Palliative (P) | null | 2015-08-21 | EVEROLIMUS | N | N | 290020686 | CAPECITABINE |
| 290005529 | 290004012 | 1.75 | 84.9 | Palliative (P) | 2014-10-20 | 2014-10-20 | Fluorouricil + Folonic Acid (MdG) | 02 | N | 290020686 | CAPECITABINE + RT |
| 290005530 | 290004013 | 1.66 | 66.5 | Neo-adjuvant (N) | null | 2018-11-02 | Paclitaxel 7 day | N | N | 290020732 | CAPECITABINE + RT |
| 290005531 | 290004014 | 1.59 | 64.5 | Neo-adjuvant (N) | 2016-04-22 | 2016-05-19 | CARBOPLATIN + RT | 2 | N | 290020741 | CISPLATIN + PEMETREXED |
| 290005532 | 290004015 | 1.68 | 70.8 | null | 2016-12-23 | 2016-12-23 | EC + PACLITAXEL | 02 | N | 290020828 | ECX |
| 290005533 | 290004016 | 1.55 | 72.7 | Not known (9) | 2013-06-08 | 2013-07-04 | LANREOTIDE | 2 | Y | 290020866 | IRINOTECAN + MDG |
| 290005534 | 290004017 | null | null | Palliative (P) | 2018-05-27 | 2018-06-22 | CAPECITABINE + GEMCITABINE | 2 | N | 290020868 | CISPLATIN + FLUOROURACIL |
| 290005535 | 290004017 | 1.64 | 63 | Adjuvant (A) | 2017-09-18 | 2017-10-16 | LANREOTIDE | N | N | 290020868 | CHOP R |
| 290005536 | 290004018 | 1.62 | 46.4 | Palliative (P) | 2016-05-02 | 2016-05-15 | FLUOROURACIL | N | N | 290020936 | CAPECITABINE + STREPTOZOCIN |
| 290005537 | 290004018 | 0 | 89.2 | Palliative (P) | 2015-12-11 | 2015-12-24 | Capecitabine + Cisplatin | 02 | null | 290020936 | IPILIMUMAB + NIVOLUMAB |
| 290005538 | 290004019 | 1.76 | null | null | 2016-11-22 | 2016-11-22 | Capecitabine | N | null | 290021044 | CAPECITABINE |
| 290005539 | 290004019 | null | null | Palliative (P) | 2016-08-22 | 2016-08-25 | Carboplatin + Etoposide IV 3 day | 02 | N | 290021044 | CISPLATIN + FLUOROURACIL |
| 290005540 | 290007818 | 1.64 | 65 | Neo-adjuvant (N) | 2017-06-28 | 2017-07-09 | CARBOPLATIN + FLUOROURACIL | 99 | N | 290021099 | TRIAL |
| 290005541 | 290007818 | 1.59 | 54 | Palliative (P) | null | 2016-09-01 | CISPLATIN + FLUOROURACIL | N | N | 290021099 | CAP |
| 290005542 | 290007818 | null | null | Palliative (P) | null | 2018-06-07 | CISPLATIN + FLUOROURACIL | N | N | 290021099 | PEMBROLIZUMAB |
| 290005543 | 290004020 | 1.65 | 39.5 | Palliative (P) | 2016-03-03 | 2016-03-03 | CHOP R | N | N | 290021377 | CISPLATIN + VINORELBINE |
| 290005544 | 290004021 | 1.69 | 72.2 | Palliative (P) | 2013-04-05 | 2013-04-05 | Cetuximab + Radiotherapy Maint | 02 | N | 290021428 | CARBOPLATIN + PEMETREXED |
| 290005545 | 290004022 | 1.7 | 53.6 | Palliative (P) | 2016-04-30 | 2016-05-22 | CISPLATIN + FLUOROURACIL | N | N | 290021449 | CISPLATIN + FLUOROURACIL |
| 290005546 | 290004022 | null | 66.4 | Curative (C) | 2015-03-23 | 2015-03-23 | Rituximab | 02 | null | 290021449 | LANREOTIDE |
| 290005547 | 290004022 | 1.57 | 54.4 | Adjuvant (A) | 2016-08-29 | 2016-08-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290021449 | CAPECITABINE |
| 290005548 | 290004022 | 1.75 | 67.6 | Adjuvant (A) | 2015-07-06 | 2015-07-07 | Capecitabine 42days + RT | 2 | N | 290021449 | CARBOPLATIN + ETOPOSIDE |
| 290005549 | 290004023 | 1.84 | null | Adjuvant (A) | 2015-05-07 | 2015-05-09 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 290021602 | CETUXIMAB |
| 290005550 | 290004024 | 1.69 | 58 | Curative (C) | 2014-11-04 | 2014-12-01 | Fluorouracil + Folinic Acid Weekly | N | Y | 290021641 | DOCETAXEL |
| 290005551 | 290004024 | 1.52 | 49.5 | Curative (C) | 2018-07-26 | 2018-07-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 290021641 | CISPLATIN + FLUOROURACIL |
| 290005552 | 290004025 | 1.68 | 67.8 | Disease modification (D) | 2015-08-03 | 2015-08-04 | Doxorubicin + Olaratumab | 02 | N | 290021740 | TRIAL |
| 290005553 | 290004026 | 1.5 | 56.1 | null | 2014-01-19 | 2014-02-18 | Cisplatin + Etoposide po&iv 3 day | Y | Y | 290021789 | CAPECITABINE + RT |
| 290005554 | 290004027 | 1.8 | 74.3 | Palliative (P) | 2016-12-23 | 2016-12-28 | Carbo F | N | N | 290021816 | EVEROLIMUS |
| 290005555 | 290004028 | null | 85.5 | Palliative (P) | 2017-09-08 | 2017-09-12 | CISPLATIN + FLUOROURACIL | N | N | 290021835 | CAPECITABINE |
| 290005556 | 290006704 | null | 51 | Palliative (P) | 2018-07-07 | 2018-07-19 | Fluorouricil + Folonic Acid (MdG) | N | N | 290021879 | FLUOROURACIL |
| 290005557 | 290004029 | 1.62 | 55 | Palliative (P) | 2018-07-16 | 2018-07-27 | Cetuximab 7 day (Cycle 1) | 2 | null | 290021884 | GEMCARBO |
| 290005558 | 290004030 | 1.62 | 81.1 | Neo-adjuvant (N) | 2014-11-12 | 2014-11-16 | Fluorouracil + Folinic Acid Weekly | N | N | 290021955 | CAPECITABINE + CISPLATIN |